Helping people gain better

Effect of Adding Liraglutide vs Placebo to a High-Dose lnsulin Regimen in Patients With Type 2 Diabetes: A Randomized Clinical Trial

Liraglutide added to high-dose insulin therapy improved glycemic control, decreased body weight, and enhanced treatment satisfaction in this difficult-to-treat patient population with high-dose insulin requirements. Further studies are warranted to confirm these findings and evaluate the long-term risk and benefit of this treatment option.  Read more at: http://archinte.jamanetwork.com/article.aspx?articleid=2526669

READY. SET. GO!!! Texas Diabetes & Endocrinology (TDE) announced today they are scheduling for the first, of a series of several, pediatric/teen research trials. This first study will be researching an investigational faster acting meal time insulin in children ages 10 to 17 years of age who are currently on multiple daily injections of insulin. TDE states they are in continued negotiations to be involved in at least three other pediatric/teen trials this year. These include investigational insulins, sensor studies and closed loops (artificial pancreas) studies. Call now (or apply online) to find out if your child qualifies for the current insulin study and stay tuned to hear more about future studies coming… 512.334.3505 Ext. 1

Time to jump in!!! On May 1st, Texas Diabetes & Endocrinology will be initiating the first, of a series of several, pediatric/teen research trials. This first study will be researching an investigational faster acting meal time insulin in children ages 10 to 17 years of age who are currently on multiple daily injections of insulin. Texas Diabetes & Endocrinology has stated they are in negotiations to be involved in at least three other pediatric/teen trials this year. These include investigational insulins, sensor studies and closed loops (artificial pancreas) studies. Call now (or apply online) to find out if your child qualifies for the study starting May 1st and stay tuned to hear more about future studies coming… 512.334.3505 Ext. 1

Texas Diabetes & Endocrinology (TDE) is continuing forward in the effort to make available research for the children and teens of Austin, TX. The first wave will include a study for Type 1 diabetic children who are currently using daily injections of basal and mealtime insulin and have been for the last 6 months. The insulin planned for study is currently being prescribed for adults with Type 1 and Type 2 diabetes. It’s time for our children and teens to have the same available insulins as adults. TDE is planning for a February enrollment start. Ready to catch the wave? Call 512-334-3505 ext. 1 or apply on the web www.texasdiabetes.com